Search results
Framework Computer Takes a Shot at PC Rivals Over AI Hype
PC Magazine· 3 hours agoMost major PC vendors are incorporating AI into their products, but not Framework Computer, which is...
Are we sure China views sea power the same way the West does?
Defense News via Yahoo News· 4 hours agoGuard alone forms the world’s largest of its kind, and its fishing fleet is the world’s largest....
Compare Big Ten football recruiting now and three weeks later
Trojans Wire via Yahoo Sports· 4 hours agoObviously, Michigan, Penn State and Ohio State will now have Oregon and USC — maybe also Washington...
Why a ‘heartland visa’ for skilled workers could be the answer to America’s immigration debate
Fortune via AOL· 9 hours agoWhen we wrote The Immigrant Exodus 11 years ago, the imperative to keep the U.S. globally...
Hot dog-eating champs Joey Chestnut and Takeru Kobayashi will go head-to head in a Netflix special
WSB-TV 2 Atlanta· 6 hours agoFourth of July hot dog-eating contest said Joey Chestnut wouldn't compete this year because of a...
Stellantis CEO cites failures in US operations, ready to compete head-on with Chinese EVs
FOX30 / CBS47 Jacksonville· 4 hours agoMILAN — (AP) — Stellantis CEO Carlos Tavares expressed dissatisfaction at the operation of some U.S....
Coach USA bus company files for bankruptcy. How will it impact NJ riders?
The Bergen Record via Yahoo Finance· 6 hours agoNJ Transit awarded Coach a seven-year, $50.1 million contract for the Passaic routes in 2017,...
Kyrie Irving praises Celtics' ‘special' defense in NBA Finals
NBC Sports Boston via Yahoo Sports· 16 minutes agoIrving was asked during a press conference Thursday about that aspect of the Celtics' defense, and...
Rivals Five-Star: Florida prospects that can boost ranking at event
Rivals via Yahoo Sports· 11 hours agoThe Rivals Five-Star is less than two weeks away, and prospects from across the country will descend...
Sarepta shares hold steady as competitor drug fails trial By Investing.com
Investing.com· 10 hours agoOn Thursday, BMO Capital maintained a positive outlook on Sarepta Therapeutics (NASDAQ:SRPT),...